接受机器人机械臂辅助全膝关节置换术的患者膝关节特异性疼痛改善优于人工全膝关节置换术但功能无差异
一项随机对照试验将100例患者分配至机器人辅助全膝关节置换术(rTKA)组或人工全膝关节置换术(mTKA)组,每组50例,术后12个月时43例rTKA和38例mTKA患者完成随访。结果显示两组在膝关节特异性量表(WOMAC、OKS、FJS)和健康相关生活质量(EQ-5D、EQ-VAS)方面无临床或统计学显著差异,但rTKA组WOMAC疼痛成分改善显著更大(p=0.029,平均差9.7,95%CI 1.0至18.4),且更可能达到「日间关节疼痛缓解」的期望(p=0.039)。
要点
- 术后12个月时,rTKA组与mTKA组在WOMAC、OKS、FJS及EQ-5D、EQ-VAS方面无临床或统计学显著差异。
- rTKA组WOMAC疼痛成分改善显著更大(p=0.029,平均差9.7,95%CI 1.0至18.4),具有临床意义。
- rTKA组更可能达到「日间关节疼痛缓解」的期望(p=0.039),其余期望满足及满意度无显著差异。
核心结论
- rTKA组在术后12个月内膝关节疼痛改善具有临床意义的更大,且更可能达到日间疼痛缓解的期望。
- 但rTKA未带来具有临床意义的膝关节特异性功能或健康相关生活质量的更大改善。
研究设计与样本
- 随机对照试验,2019年5月至2021年12月开展,共100例患者随机分配至mTKA组或rTKA组,每组50例。
- 术后12个月时43例rTKA和38例mTKA患者可随访,两组术前无统计学显著差异。
主要发现
- 术后12个月时,两组在WOMAC、OKS、FJS或EQ-5D、EQ-VAS方面无临床或统计学显著差异。
- rTKA组WOMAC疼痛成分在术后2、6、12个月改善显著更大(p=0.029,平均差9.7,95%CI 1.0至18.4),具有临床意义。
- WOMAC功能(p=0.248)或总分(p=0.147)未观察到显著差异。
- rTKA组更可能达到「日间关节疼痛缓解」的期望(p=0.039),其余期望满足无显著差异。
- 患者对膝关节满意度(p=0.464)、重返工作(p=0.464)、活动(p=0.293)或疼痛(p=0.701)无显著差异。
关键数值与推荐
- WOMAC疼痛评分的最小临床重要差异定义为7.5分。
- rTKA组WOMAC疼痛成分平均差9.7(95%CI 1.0至18.4,p=0.029),超过最小临床重要差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim was to assess whether robotic-assisted total knee arthroplasty (rTKA) had greater knee-specific outcomes, improved fulfilment of expectations, health-related quality of life (HRQoL), and patient satisfaction when compared with manual TKA (mTKA). METHODS: A randomized controlled trial was undertaken (May 2019 to December 2021), and patients were allocated to either mTKA or rTKA. A total of 100 patients were randomized, 50 to each group, of whom 43 rTKA and 38 mTKA patients were available for review at 12 months following surgery. There were no statistically significant preoperative differences between the groups. The minimal clinically important difference in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score was defined as 7.5 points. RESULTS: There were no clinically or statistically significant differences between the knee-specific measures (WOMAC, Oxford Knee Score (OKS), Forgotten Joint Score (FJS)) or HRQoL measures (EuroQol five-dimension questionnaire (EQ-5D) and EuroQol visual analogue scale (EQ-VAS)) at 12 months between the groups. However, the rTKA group had significantly (p = 0.029) greater improvements in the WOMAC pain component (mean difference 9.7, 95% confidence interval (CI) 1.0 to 18.4) over the postoperative period (two, six, and 12 months), which was clinically meaningful. This was not observed for function (p = 0.248) or total (p = 0.147) WOMAC scores. The rTKA group was significantly (p = 0.039) more likely to have expectation of 'Relief of daytime pain in the joint' when compared with the mTKA group. There were no other significant differences in expectations met between the groups. There was no significant difference in patient satisfaction with their knee (p = 0.464), return to work (p = 0.464), activities (p = 0.293), or pain (p = 0.701). CONCLUSION: Patients undergoing rTKA had a clinically meaningful greater improvement in their knee pain over the first 12 months, and were more likely to have fulfilment of their expectation of daytime pain relief compared with patients undergoing mTKA. However, rTKA was not associated with a clinically significant greater knee-specific function or HRQoL, according to current definitions.
引用
- Clement ND, Galloway S, Baron J, et al. Patients undergoing robotic arm-assisted total knee arthroplasty have a greater improvement in knee-specific pain but not in function. Bone Joint J. 2024. PMID: 38688485. doi:10.1302/0301-620X.106B5.BJJ-2023-1196.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。